Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Topics in Virology   Volumes    Volume 16 
Current and novel methods for Hepatitis C incidence estimation in blood donors
Emil Kupek
Pages: 61 - 73
Number of pages: 13
Current Topics in Virology
Volume 16 

Copyright © 2019 Research Trends. All rights reserved

Incidence-window period (IWP) and nucleic acid amplification testing (NAT) are the most widely used methods to estimate the incidence of transfusion-transmitted infections, including the hepatitis C virus (HCV) infection. The majority of HCV-infected people live in low and middle-income countries with only a serological screening of blood donors. A modification of the IWP method was proposed to include probabilistic case definition (PCD) of repeat blood donors whose prior donation was HIV-negative and occurred before the study start. First-time donor incidence was estimated by multiplying repeat donor incidence with repeat-to-first-time-donor prevalence ratio. Both methods were tested with artificial data with varying HCV prevalence (low, high), donor type (repeat, first-time) and donor follow-up (5 and 10 years). A real data example from the Santa Catarina state in southern Brazil was also provided. In the artificial data, the bias reduction of IWP-PCD compared to IWP incidence ranged between 95 and 100%. Real data analysis showed the HCV incidence per 100.000 person-years of 20.50 with 95% confidence interval (CI) of 7.52-44.62, and 6.84 (95% CI 0.82-24.70) for the IWP and IWP-PCD method, respectively, among repeat donors. Overall IWP incidence on the same scale by IWP was about threefold the IWP-PCD estimate of 32.5. Large bias reduction of the IWP incidence estimates due to IWP-PCD method with artificial data for both low and high prevalence scenario indicates a great potential of the latter method for blood donor screening in settings which rely only on serological testing. A relatively small number of donations, such as those found in regional blood banks, could be suitable for the IWP-PCD incidence and residual risk estimation. Recent changes in incidence for monitoring and surveillance could be detected more promptly than by widely used prevalence trends.
Buy this Article


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms